Fat Burner

A two-compound metabolic research model targeting fat metabolism through distinct mechanisms. AOD-9604 activates GH fragment lipolytic signaling, while 5-Amino-1MQ inhibits NNMT enzyme activity.

AOD-9604 (Advanced Obesity Drug 9604) is a stabilized 16-amino acid fragment of human growth hormone that has been studied for its ability to activate the GH receptor's fat-metabolizing domain without triggering the growth-promoting effects of full-length GH. 5-Amino-1MQ is a small-molecule NNMT (nicotinamide N-methyltransferase) inhibitor that raises intracellular SAM availability, creating a metabolic shift that promotes white adipose tissue browning.

Key Research Areas

• Dual-mechanism fat metabolism research model
• GH fragment lipolytic signaling investigation
• NNMT enzyme inhibition and methionine cycle modulation
• White adipose browning pathway studies

Research Applications

• GH fragment receptor pharmacology studies
• NNMT inhibitor and adipose tissue browning research
• SAM cycle modulation and metabolic reprogramming investigation
• Non-overlapping fat oxidation pathway interaction modeling

Bundle Savings

This research stack includes a 10% discount compared to purchasing compounds individually. All components are third-party tested with Certificates of Analysis available for each batch.

For research use only. Not for human or animal consumption.